Table 3: Reactivity of SEREX-Defined Antigens Screened with Sera from Healthy Donors and Patients with Prostate Cancer

Designation Identity Serological reactivity
Control Pca
Pr1 Trans-Golgi P230 autoantigen 5-May 9-Sep
Pr2 aarF domain containing kinase 4 0/14 4/13
Pr3 Unknown 2/14 6/7
Pr4 SATB2 1/14 2/13
Pr5 Mitochondrical protein 0/4 0/9
Pr6 Unknown 3/13 12/14
Pr7 Ribosomal protein S8 6/13 13/14
Pr8 Ribosomal protein L27a 0/13 1/14
Pr9 Hypothetical protein LOC116228 1/10 1/7
Pr10 Similar to AB25 2/13 6/14
Pr11 Unknown 0/7 0/6
Pr12 DNA-binding protein (HRC1) 0/13 0/8
Pr13 A alternatively spliced isoform of HRC1 0/13 1/8
Pr14 Geminin, DNA replication inhibitor 1/13 1/8
Pr15 Calcium binding protein (ALG-2) 1/17 4/13
Pr16 Metastasis-associated1 (MTA1) mRNA 0/13 2/13
Pr17 NEDD8 ultimate buster-1 1/17 1/13
Pr18 Surfeit 6 4/13 3/8
Pr19 Phospholipase C-gamma mRNA 0/13 0/8
Pr20 Scaffold attachment factor A 0/13 0/8
Pr21 Upstream transcription factor 2, c-fos interacting 0/13 0/8
Pr22 Ubiquitin specific protease 8 3/17 7/13
Pr23 Vesicle docking protein p115 0/13 0/8
Pr24 Proteasome subunit HSPC 6/17 10/13
Pr25 fatty-acid-Coenzyme A ligase, long-chain 5 4/17 8/13
Pr26 F1F0-type ATP synthase subunit d mRNA 0/13 0/8
Pr27 glutamyl-prolyl-tRNA synthetase 5/17 10/13
Pr28 Ribosimal protein L10 2/6 5/10
Pr29 Ribosomal protein S14 2/5 5/10
Pr30 Ribosomal protein L18a 3/5 4/10
Pr31 Ribosomal protein S10 0/4 5/10
Pr32 Ribosomal protein L32 0/4 0/10
Pr35 Tankyrase 2/4 4/10
Pr41 Cell death-regulatory protein GRIM19 0/6 5/12
Pr52 Unknown 2/11 13-Nov